AlphaFold predicted structure
AICDA · Q9GZX7

Mean pLDDT
88.2/ 100
Confident
198 residues
Confidence breakdown
- Very high(≥ 90)72%
- Confident(70–90)14%
- Low(50–70)13%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
activation induced cytidine deaminase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalInfantile enterocolitis & monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalGastrointestinal epithelial barrier disorders
BIALLELIC, autosomal or pseudoautosomalhyper-IgM syndrome type 2
hereditary disease
B-cell chronic lymphocytic leukemia
diffuse large B-cell lymphoma
acute lymphoblastic leukemia
cancer
infection
myeloid sarcoma
lymphoma
Alzheimer disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Single-stranded DNA cytosine deaminase
Single-stranded DNA-specific cytidine deaminase. Involved in somatic hypermutation (SHM), gene conversion, and class-switch recombination (CSR) in B-lymphocytes by deaminating C to U during transcription of Ig-variable (V) and Ig-switch (S) region DNA. Required for several crucial steps of B-cell terminal differentiation necessary for efficient antibody responses (PubMed:18722174, PubMed:21385873, PubMed:21518874, PubMed:27716525). May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation (PubMed:21496894)
AICDA · Q9GZX7

Mean pLDDT
88.2/ 100
Confident
198 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0